The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism

References

• Takuma N., Sheng H. Z., Furuta Y., Ward J. M., Sharma K., Hogan L. M., et al. Formation of Rathke's pouch requires dual induction from the diencephalon. Development 1998; 125: 4835–40
   PubMed Web of Science ®Google Scholar
• Dasen J. S., Rosenfeld M. G. Signaling mechanisms in pituitary morphogenesis and cell fate determination. Curr Opin Cell Biol 1999; 11: 669–77
   PubMed Web of Science ®Google Scholar
• Dasen J. S., Rosenfeld M. G. Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci 2001; 24: 327–55
   PubMed Web of Science ®Google Scholar
• Rizzoti K., Lovell‐Badge R. Early development of the pituitary gland: induction and shaping of Rathke's pouch. Rev Endocr Metab Disord 2005; 6: 161–72
   PubMed Web of Science ®Google Scholar
• Cohen R. N. Update on genetic regulation of pituitary development. Pediatr Endocrinol Rev 2006; 3(Suppl 2)312–7
   Google Scholar
• GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990–3
   PubMed Web of Science ®Google Scholar
• Parkin J. M. Incidence of growth hormone deficiency. Arch Dis Child 1974; 49: 904–5
   PubMed Web of Science ®Google Scholar
• Vimpani G. V., Vimpani A. F., Lidgard G. P., Cameron E. H., Farquhar J. W. Prevalence of severe growth hormone deficiency. Br Med J 1977; 2: 427–30
   PubMed Web of Science ®Google Scholar
• Lindsay R., Feldkamp M., Harris D., Robertson J., Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994; 125: 29–35
   PubMed Web of Science ®Google Scholar
• Bao X. L., Shi Y. F., Du Y. C., Liu R., Deng J. Y., Gao S. M. Prevalence of growth hormone deficiency of children in Beijing. Chin Med J (Engl) 1992; 105: 401–5
   PubMed Web of Science ®Google Scholar
• Thomas M., Massa G., Craen M., de Z. F., Bourguignon J. P., Heinrichs C., et al. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986–2001. Eur J Endocrinol 2004; 151: 67–72
   PubMed Web of Science ®Google Scholar
• Phillips J. A III., Cogan J. D. Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 11–6
   PubMed Web of Science ®Google Scholar
• Patel L., McNally R. J., Harrison E., Lloyd I. C., Clayton P. E. Geographical distribution of optic nerve hypoplasia and septo‐optic dysplasia in Northwest England. J Pediatr 2006; 148: 85–8
   PubMed Web of Science ®Google Scholar
• Tornqvist K., Ericsson A., Kallen B. Optic nerve hypoplasia: Risk factors and epidemiology. Acta Ophthalmol Scand 2002; 80: 300–4
   PubMedGoogle Scholar
• Hermesz E., Mackem S., Mahon K. A. Rpx: a novel anterior‐restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 1996; 122: 41–52
   PubMed Web of Science ®Google Scholar
• Thomas P. Q., Johnson B. V., Rathjen J., Rathjen P. D. Sequence, genomic organization, and expression of the novel homeobox gene Hesx1. J Biol Chem 1995; 270: 3869–75
   PubMed Web of Science ®Google Scholar
• Dasen J. S., Barbera J. P., Herman T. S., Connell S. O., Olson L., Ju B., et al. Temporal regulation of a paired‐like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 2001; 15: 3193–207
   PubMed Web of Science ®Google Scholar
• Sornson M. W., Wu W., Dasen J. S., Flynn S. E., Norman D. J., O'Connell S. M., et al. Pituitary lineage determination by the Prophet of Pit‐1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327–33
   PubMed Web of Science ®Google Scholar
• Thomas P., Beddington R. Anterior primitive endoderm may be responsible for patterning the anterior neural plate in the mouse embryo. Curr Biol 1996; 6: 1487–96
   PubMed Web of Science ®Google Scholar
• Chou S. J., Hermesz E., Hatta T., Feltner D., El‐Hodiri H. M., Jamrich M., et al. Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development. Dev Biol 2006; 292: 533–45
   PubMed Web of Science ®Google Scholar
• Dattani M. T., Martinez‐Barbera J. P., Thomas P. Q., Brickman J. M., Gupta R., Martensson I. L., et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo‐optic dysplasia in human and mouse. Nat Genet 1998; 19: 125–33
   PubMed Web of Science ®Google Scholar
• Brickman J. M., Clements M., Tyrell R., McNay D., Woods K., Warner J., et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001; 128: 5189–99
   PubMed Web of Science ®Google Scholar
• Wales J. K., Quarrell O. W. Evidence for possible Mendelian inheritance of septo‐optic dysplasia. Acta Paediatr 1996; 85: 391–2
   PubMed Web of Science ®Google Scholar
• Carvalho L. R., Woods K. S., Mendonca B. B., Marcal N., Zamparini A. L., Stifani S., et al. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor‐corepressor interaction. J Clin Invest 2003; 112: 1192–201
   PubMed Web of Science ®Google Scholar
• Sobrier M. L., Netchine I., Heinrichs C., Thibaud N., Vie‐Luton M. P., Van V. G., et al. Alu‐element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum Mutat 2005; 25: 503
   PubMedGoogle Scholar
• Sobrier M. L., Maghnie M., Vie‐Luton M. P., Secco A., di Iorgi N., Lorini R., et al. Novel HESX1 mutations associated with a life‐threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. J Clin Endocrinol Metab, 2006 Aug 29 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Arrigo T., Wasniewska M., De Luca F., Valenzise M., Lombardo F., Vivenza D., et al. Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development. J Endocrinol Invest 2006; 29: 208–13
   PubMed Web of Science ®Google Scholar
• Thomas P. Q., Dattani M. T., Brickman J. M., McNay D., Warne G., Zacharin M., et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo‐optic dysplasia. Hum Mol Genet 2001; 10: 39–45
   PubMed Web of Science ®Google Scholar
• Cohen R. N., Cohen L. E., Botero D., Yu C., Sagar A., Jurkiewicz M., et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003; 88: 4832–9
   PubMed Web of Science ®Google Scholar
• Tajima T., Hattorri T., Nakajima T., Okuhara K., Sato K., Abe S., et al. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 2003; 88: 45–50
   PubMed Web of Science ®Google Scholar
• Gage P. J., Brinkmeier M. L., Scarlett L. M., Knapp L. T., Camper S. A., Mahon K. A. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage‐specific cell proliferation. Mol Endocrinol 1996; 10: 1570–81
   PubMedGoogle Scholar
• Ward R. D., Raetzman L. T., Suh H., Stone B. M., Nasonkin I. O., Camper S. A. Role of PROP1 in pituitary gland growth. Mol Endocrinol 2005; 19: 698–710
   PubMedGoogle Scholar
• Ward R. D., Stone B. M., Raetzman L. T., Camper S. A. Cell Proliferation and Vascularization in Mouse Models of Pituitary Hormone Deficiency. Mol Endocrinol 2006; 20: 1378–90
   PubMedGoogle Scholar
• Tang K., Bartke A., Gardiner C. S., Wagner T. E., Yun J. S. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. Endocrinology 1993; 132: 2518–24
   PubMed Web of Science ®Google Scholar
• Nasonkin I. O., Ward R. D., Raetzman L. T., Seasholtz A. F., Saunders T. L., Gillespie P. J., et al. Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 2004; 13: 2727–35
   PubMed Web of Science ®Google Scholar
• Wu W., Cogan J. D., Pfaffle R. W., Dasen J. S., Frisch H., O'Connell S. M., et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147–9
   PubMed Web of Science ®Google Scholar
• Deladoey J., Fluck C., Buyukgebiz A., Kuhlmann B. V., Eble A., Hindmarsh P. C., et al. ‘Hot spot’ in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999; 84: 1645–50
   PubMed Web of Science ®Google Scholar
• Cogan J. D., Wu W., Phillips J. A., Arnhold I. J., Agapito A., Fofanova O. V., et al. The PROP1 2‐base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346–9
   PubMed Web of Science ®Google Scholar
• Turton J. P. G., Mehta A., Raza J., Woods K. S., Tiulpakov A., Cassar J., et al. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clin Endocrinol (Oxf) 2005; 63: 10–8
   PubMed Web of Science ®Google Scholar
• Duquesnoy P., Roy A., Dastot F., Ghali I., Teinturier C., Netchine I., et al. Human Prop‐1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency. FEBS Lett 1998; 437: 216–20
   PubMed Web of Science ®Google Scholar
• Parks J. S., Brown M. R., Hurley D. L., Phelps C. J., Wajnrajch M. P. Heritable disorders of pituitary development. J Clin Endocrinol Metab 1999; 84: 4362–70
   PubMed Web of Science ®Google Scholar
• Voutetakis A., Maniati‐Christidi M., Kanaka‐Gantenbein C., Dracopoulou M., Argyropoulou M., Livadas S., et al. Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X). Eur J Endocrinol 2004; 150: 257–64
   PubMed Web of Science ®Google Scholar
• Vallette‐Kasic S., Barlier A., Teinturier C., Diaz A., Manavela M., Berthezene F., et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001; 86: 4529–35
   PubMed Web of Science ®Google Scholar
• Osorio M. G., Kopp P., Marui S., Latronico A. C., Mendonca B. B., Arnhold I. J. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP‐1. J Clin Endocrinol Metab 2000; 85: 2779–85
   PubMed Web of Science ®Google Scholar
• Lebl J., Vosahlo J., Pfaeffle R. W., Stobbe H., Cerna J., Novotna D., et al. Auxological and endocrine phenotype in a population‐based cohort of patients with PROP1 gene defects. Eur J Endocrinol 2005; 153: 389–96
   PubMed Web of Science ®Google Scholar
• Vieira T. C., Dias da Silva M. R., Cerutti J. M., Brunner E., Borges M., Arnaldi L. T., et al. Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of Prophet of Pit‐1 presenting as constitutional growth delay. J Clin Endocrinol Metab 2003; 88: 38–44
   PubMed Web of Science ®Google Scholar
• Paracchini R., Giordano M., Corrias A., Mellone S., Matarazzo P., Bellone J., et al. Two new PROP1 gene mutations responsible for compound pituitary hormone deficiency. Clin Genet 2003; 64: 142–7
   PubMed Web of Science ®Google Scholar
• Lemos M. C., Gomes L., Bastos M., Leite V., Limbert E., Carvalho D., et al. PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 2006; 65: 479–85
   PubMed Web of Science ®Google Scholar
• Fofanova O. V., Takamura N., Kinoshita E., Parks J. S., Brown M. R., Peterkova V. A., et al. A mutational hot spot in the Prop‐1 gene in Russian children with combined pituitary hormone deficiency. Pituitary 1998; 1: 45–9
   PubMedGoogle Scholar
• Agarwal G., Bhatia V., Cook S., Thomas P. Q. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 2000; 85: 4556–61
   PubMed Web of Science ®Google Scholar
• Tatsumi K. I., Kikuchi K., Tsumura K., Amino N. A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency. Clin Endocrinol (Oxf) 2004; 61: 635–40
   PubMed Web of Science ®Google Scholar
• Nose O., Tatsumi K., Nakano Y., Amino N. Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT). J Pediatr Endocrinol Metab 2006; 19: 491–8
   PubMed Web of Science ®Google Scholar
• Reynaud R., Gueydan M., Saveanu A., Vallette‐Kasic S., Enjalbert A., Brue T., et al. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J Clin Endocrinol Metab 2006; 91: 3329–36
   PubMed Web of Science ®Google Scholar
• Bottner A., Keller E., Kratzsch J., Stobbe H., Weigel J. F., Keller A., et al. PROP1 Mutations Cause Progressive Deterioration of Anterior Pituitary Function including Adrenal Insufficiency: A Longitudinal Analysis. J Clin Endocrinol Metab 2004; 89: 5256–65
   PubMed Web of Science ®Google Scholar
• Abrao M. G., Leite M. V., Carvalho L. R., Billerbeck A. E., Nishi M. Y., Barbosa A. S., et al. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin Endocrinol (Oxf) 2006; 65: 294–300
   PubMed Web of Science ®Google Scholar
• Reynaud R., Chadli‐Chaieb M., Vallette‐Kasic S., Barlier A., Sarles J., Pellegrini‐Bouiller I., et al. A Familial Form of Congenital Hypopituitarism Due to a PROP1 Mutation in a Large Kindred: Phenotypic and in Vitro Functional Studies. J Clin Endocrinol Metab 2004; 89: 5779–86
   PubMed Web of Science ®Google Scholar
• Mendonca B. B., Osorio M. G., Latronico A. C., Estefan V., Lo L. S., Arnhold I. J. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J Clin Endocrinol Metab 1999; 84: 942–5
   PubMed Web of Science ®Google Scholar
• Fofanova O., Takamura N., Kinoshita E., Parks J. S., Brown M. R., Peterkova V. A., et al. Compound heterozygous deletion of the PROP‐1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 2601–4
   PubMed Web of Science ®Google Scholar
• Reynaud R., Barlier A., Vallette‐Kasic S., Saveanu A., Guillet M. P., Simonin G., et al. An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 2005; 90: 4880–7
   PubMed Web of Science ®Google Scholar
• Arroyo A., Pernasetti F., Vasilyev V. V., Amato P., Yen S. S., Mellon P. L. A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf) 2002; 57: 283–91
   PubMed Web of Science ®Google Scholar
• Fluck C., Deladoey J., Rutishauser K., Eble A., Marti U., Wu W., et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg–>Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998; 83: 3727–34
   PubMed Web of Science ®Google Scholar
• Voutetakis A., Argyropoulou M., Sertedaki A., Livadas S., Xekouki P., Maniati‐Christidi M., et al. Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab 2004; 89: 2200–6
   PubMed Web of Science ®Google Scholar
• Asteria C., Oliveira J. H., Abucham J., Beck‐Peccoz P. Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP‐1 gene. Eur J Endocrinol 2000; 143: 347–52
   PubMed Web of Science ®Google Scholar
• Pernasetti F., Toledo S. P., Vasilyev V. V., Hayashida C. Y., Cogan J. D., Ferrari C., et al. Impaired adrenocorticotropin‐adrenal axis in combined pituitary hormone deficiency caused by a two‐base pair deletion (301‐302delAG) in the prophet of Pit‐1 gene. J Clin Endocrinol Metab 2000; 85: 390–7
   PubMed Web of Science ®Google Scholar
• Riepe F. G., Partsch C. J., Blankenstein O., Monig H., Pfaffle R. W., Sippell W. G. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J Clin Endocrinol Metab 2001; 86: 4353–7
   PubMed Web of Science ®Google Scholar
• Vesper A. H., Raetzman L. T., Camper S. A. Role of prophet of Pit1 (PROP1) in gonadotrope differentiation and puberty. Endocrinology 2006; 147: 1654–63
   PubMed Web of Science ®Google Scholar
• Fofanova O., Takamura N., Kinoshita E., Vorontsov A., Vladimirova V., Dedov I., et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. AJR Am J Roentgenol 2000; 174: 555–9
   PubMed Web of Science ®Google Scholar
• Parks J. S., Brown M. R., Baumbach L., Sanchez J. C., Stanley C. A., Gianella‐Neto D., et al. Natural history and molecular mechanisms of hypopituitarism with large sella turcica. Presented at the American Endocrine Society Meeting, New Orleans, June 24–27, 1998. Abstract no. P3‐409. 1998; 470
   Google Scholar
• Cushman L. J., Watkins‐Chow D. E., Brinkmeier M. L., Raetzman L. T., Radak A. L., Lloyd R. V., et al. Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility. Hum Mol Genet 2001; 10: 1141–53
   PubMed Web of Science ®Google Scholar
• Olson L. E., Tollkuhn J., Scafoglio C., Krones A., Zhang J., Ohgi K. A., et al. Homeodomain‐mediated beta‐catenin‐dependent switching events dictate cell‐lineage determination. Cell 2006; 125: 593–605
   PubMed Web of Science ®Google Scholar
• Bodner M., Castrillo J. L., Theill L. E., Deerinck T., Ellisman M., Karin M. The pituitary‐specific transcription factor GHF‐1 is a homeobox‐containing protein. Cell 1988; 55: 505–18
   PubMed Web of Science ®Google Scholar
• Andersen B., Rosenfeld M. G. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 2001; 22: 2–35
   PubMed Web of Science ®Google Scholar
• Rhodes S. J., DiMattia G. E., Rosenfeld M. G. Transcriptional mechanisms in anterior pituitary cell differentiation. Curr Opin Genet Dev 1994; 4: 709–17
   PubMed Web of Science ®Google Scholar
• Li S., Crenshaw E. B III., Rawson E. J., Simmons D. M., Swanson L. W., Rosenfeld M. G. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU‐domain gene pit‐1. Nature 1990; 347: 528–33
   PubMed Web of Science ®Google Scholar
• Andersen B., Rosenfeld M. G. Pit‐1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 1994; 269: 29335–8
   PubMed Web of Science ®Google Scholar
• Rhodes S. J., Chen R., DiMattia G. E., Scully K. M., Kalla K. A., Lin S. C., et al. A tissue‐specific enhancer confers Pit‐1‐dependent morphogen inducibility and autoregulation on the pit‐1 gene. Genes Dev 1993; 7: 913–32
   PubMed Web of Science ®Google Scholar
• Tatsumi K., Miyai K., Notomi T., Kaibe K., Amino N., Mizuno Y., et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992; 1: 56–8
   PubMed Web of Science ®Google Scholar
• Cohen L. E., Wondisford F. E., Salvatoni A., Maghnie M., Brucker‐Davis F., Weintraub B. D., et al. A ‘hot spot’ in the Pit‐1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995; 80: 679–84
   PubMed Web of Science ®Google Scholar
• Ohta K., Nobukuni Y., Mitsubuchi H., Fujimoto S., Matsuo N., Inagaki H., et al. Mutations in the Pit‐1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992; 189: 851–5
   PubMed Web of Science ®Google Scholar
• Radovick S., Nations M., Du Y., Berg L. A., Weintraub B. D., Wondisford F. E. A mutation in the POU‐homeodomain of Pit‐1 responsible for combined pituitary hormone deficiency. Science 1992; 257: 1115–8
   PubMed Web of Science ®Google Scholar
• Okamoto N., Wada Y., Ida S., Koga R., Ozono K., Chiyo H., et al. Monoallelic expression of normal mRNA in the PIT1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype. Hum Mol Genet 1994; 3: 1565–8
   PubMed Web of Science ®Google Scholar
• de Zegher F., Pernasetti F., Vanhole C., Devlieger H., Van den Berghe G., Martial J. A. The prenatal role of thyroid hormone evidenced by fetomaternal Pit‐1 deficiency. J Clin Endocrinol Metab 1995; 80: 3127–30
   PubMed Web of Science ®Google Scholar
• Holl R. W., Pfaffle R., Kim C., Sorgo W., Teller W. M., Heimann G. Combined pituitary deficiencies of growth hormone, thyroid stimulating hormone and prolactin due to Pit‐1 gene mutation: a case report. Eur J Pediatr 1997; 156: 835–7
   PubMed Web of Science ®Google Scholar
• Aarskog D., Eiken H. G., Bjerknes R., Myking O. L. Pituitary dwarfism in the R271W Pit‐1 gene mutation. Eur J Pediatr 1997; 156: 829–34
   PubMed Web of Science ®Google Scholar
• Rodrigues Martineli A. M., Braga M., De Lacerda L., Raskin S., Graf H. Description of a Brazilian patient bearing the R271W Pit‐1 gene mutation. Thyroid 1998; 8: 299–304
   PubMed Web of Science ®Google Scholar
• Ward L., Chavez M., Huot C., Lecocq P., Collu R., Decarie J. C., et al. Severe congenital hypopituitarism with low prolactin levels and age‐dependent anterior pituitary hypoplasia: a clue to a PIT‐1 mutation. J Pediatr 1998; 132: 1036–8
   PubMed Web of Science ®Google Scholar
• Cohen R. N., Brue T., Naik K., Houlihan C. A., Wondisford F. E., Radovick S. The role of CBP/p300 interactions and Pit‐1 dimerization in the pathophysiological mechanism of combined pituitary hormone deficiency. J Clin Endocrinol Metab 2006; 91: 239–47
   PubMed Web of Science ®Google Scholar
• Kishimoto M., Okimura Y., Fumoto M., Iguchi G., Iida K., Kaji H., et al. The R271W mutant form of Pit‐1 does not act as a dominant inhibitor of Pit‐1 action to activate the promoters of GH and prolactin genes. Eur J Endocrinol 2003; 148: 619–25
   PubMed Web of Science ®Google Scholar
• Pfaffle R. W., DiMattia G. E., Parks J. S., Brown M. R., Wit J. M., Jansen M., et al. Mutation of the POU‐specific domain of Pit‐1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257: 1118–21
   PubMed Web of Science ®Google Scholar
• Pfaffle R. W., Martinez R., Kim C., Frisch H., Lebl J., Otten B., et al. GH and TSH deficiency. Exp Clin Endocrinol Diabetes 1997; 105(Suppl 4)1–5
   PubMedGoogle Scholar
• Turton J. P. G., Reynaud R., Mehta A., Torpiano J., Saveanu A., Woods K. S., et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005; 90: 4762–70
   PubMed Web of Science ®Google Scholar
• Cohen L. E., Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002; 23: 431–42
   PubMed Web of Science ®Google Scholar
• Bach I., Rhodes S. J., Pearse R. V., Heinzel T., Gloss B., Scully K. M., et al. P‐Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit‐1. Proc Natl Acad Sci U S A 1995; 92: 2720–4
   PubMed Web of Science ®Google Scholar
• Schmitt S., Biason‐Lauber A., Betts D., Schoenle E. J. Genomic structure, chromosomal localization, and expression pattern of the human LIM‐homeobox3 (LHX 3) gene. Biochem Biophys Res Commun 2000; 274: 49–56
   PubMed Web of Science ®Google Scholar
• Zhadanov A. B., Bertuzzi S., Taira M., Dawid I. B., Westphal H. Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 1995; 202: 354–64
   PubMed Web of Science ®Google Scholar
• Sheng H. Z., Zhadanov A. B., Mosinger B., Fujii T., Bertuzzi S., Grinberg A., et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996; 272: 1004–7
   PubMed Web of Science ®Google Scholar
• Sheng H. Z., Moriyama K., Yamashita T., Li H., Potter S. S., Mahon K. A., et al. Multistep control of pituitary organogenesis. Science 1997; 278: 1809–12
   PubMed Web of Science ®Google Scholar
• Netchine I., Sobrier M. L., Krude H., Schnabel D., Maghnie M., Marcos E., et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000; 25: 182–6
   PubMed Web of Science ®Google Scholar
• Sloop K. W., Parker G. E., Hanna K. R., Wright H. A., Rhodes S. J. LHX3 transcription factor mutations associated with combined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 2001; 265: 61–9
   PubMed Web of Science ®Google Scholar
• Bhangoo A. P., Hunter C. S., Savage J. J., Anhalt H., Pavlakis S., Walvoord E. C., et al. Clinical case seminar: A Novel LHX3 Mutation Presenting as Combined Pituitary Hormonal Deficiency. J Clin Endocrinol Metab 2006; 91: 747–53
   PubMed Web of Science ®Google Scholar
• Sobrier M. L., Attie‐Bitach T., Netchine I., Encha‐Razavi F., Vekemans M., Amselem S. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr Patterns 2004; 5: 279–84
   PubMed Web of Science ®Google Scholar
• Machinis K., Pantel J., Netchine I., Leger J., Camand O. J. A., Sobrier M. L., et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001; 69: 961–8
   PubMed Web of Science ®Google Scholar
• Machinis K., Amselem S. Functional relationship between LHX4 and POU1F1 in light of the LHX4 mutation identified in patients with pituitary defects. J Clin Endocrinol Metab 2005; 90: 5456–62
   PubMed Web of Science ®Google Scholar
• Hamel B. C., Smits A. P., Otten B. J., van den Helm B., Ropers H. H., Mariman E. C. Familial X‐linked mental retardation and isolated growth hormone deficiency: clinical and molecular findings. Am J Med Genet 1996; 64: 35–41
   PubMed Web of Science ®Google Scholar
• Hol F. A., Schepens M. T., van Beersum S. E., Redolfi E., Affer M., Vezzoni P., et al. Identification and characterization of an Xq26‐q27 duplication in a family with spina bifida and panhypopituitarism suggests the involvement of two distinct genes. Genomics 2000; 69: 174–81
   PubMed Web of Science ®Google Scholar
• Solomon N. M., Nouri S., Warne G. L., Lagerstrom‐Fermer M., Forrest S. M., Thomas P. Q. Increased gene dosage at Xq26‐q27 is associated with X‐linked hypopituitarism. Genomics 2002; 79: 553–9
   PubMed Web of Science ®Google Scholar
• Solomon N. M., Ross S. A., Morgan T., Belsky J. L., Hol F. A., Karnes P. S., et al. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 2004; 41: 669–78
   PubMed Web of Science ®Google Scholar
• Woods K. S., Cundall M., Turton J., Rizotti K., Mehta A., Palmer R., et al. Over‐ and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005; 76: 833–49
   PubMed Web of Science ®Google Scholar
• Laumonnier F., Ronce N., Hamel B. C. J., Thomas P., Lespinasse J., Raynaud M., et al. Transcription factor SOX3 is involved in X‐linked mental retardation with growth hormone deficiency. Am J Hum Genet 2002; 71: 1450–5
   PubMed Web of Science ®Google Scholar
• Rizzoti K., Brunelli S., Carmignac D., Thomas P. Q., Robinson I. C., Lovell‐Badge R. SOX3 is required during the formation of the hypothalamo‐pituitary axis. Nat Genet 2004; 36: 247–55
   PubMed Web of Science ®Google Scholar
• Wood H. B., Episkopou V. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre‐gastrulation to early somite stages. Mech Dev 1999; 86: 197–201
   PubMed Web of Science ®Google Scholar
• Williamson K. A., Hever A. M., Rainger J., Rogers R. C., Magee A., Fiedler Z., et al. Mutations in SOX2 Cause Anophthalmia‐Esophageal‐Genital (AEG) Syndrome. Hum Mol Genet 2006; 15: 1413–22
   PubMed Web of Science ®Google Scholar
• Avilion A. A., Nicolis S. K., Pevny L. H., Perez L., Vivian N., Lovell‐Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126–40
   PubMed Web of Science ®Google Scholar
• Kelberman D., Rizzoti K., Avilion A., Bitner‐Glindzicz M., Cianfarani S., Collins J., et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo‐pituitary‐gonadal axis in mice and humans. J Clin Invest 2006; 116: 2442–55
   PubMed Web of Science ®Google Scholar
• Fantes J., Ragge N. K., Lynch S. A., Mcgill N. I., Collin J. R. O., Howard‐Peebles P. N., et al. Mutations in SOX2 cause anophthalmia. Nat Genet 2003; 33: 461–3
   PubMed Web of Science ®Google Scholar
• Ragge N. K., Lorenz B., Schneider A., Bushby K., de Sanctis L., de Sanctis U., et al. SOX2 anophthalmia syndrome. Am J Med Genet A 2005; 135A: 1–7
   Web of Science ®Google Scholar
• Hagstrom S. A., Pauer G. J. T., Reid J., Simpson E., Crowe S., Maumenee I. H., et al. SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies. Am J Med Genet A 2005; 138A: 95–8
   PubMed Web of Science ®Google Scholar
• Zenteno J. C., Gascon‐Guzman G., Tovilla‐Canales J. L. Bilateral anophthalmia and brain malformations caused by a 20‐bp deletion in the SOX2 gene. Clin Genet 2005; 68: 564–6
   PubMed Web of Science ®Google Scholar
• Lamolet B., Pulichino A., Lamonerie T., Gauthier Y., Brue T., Enjalbert A., et al. A Pituitary Cell‐Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins. Cell 2001; 104: 849–59
   PubMed Web of Science ®Google Scholar
• Liu J., Lin C., Gleiberman A., Ohgi K. A., Herman T., Huang H. P., et al. Tbx19, a tissue‐selective regulator of POMC gene expression. Proc Natl Acad Sci U S A 2001; 98: 8674–9
   PubMed Web of Science ®Google Scholar
• Pulichino A. M., Vallette‐Kasic S., Tsai J. P., Couture C., Gauthier Y., Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 2003; 17: 738–47
   PubMed Web of Science ®Google Scholar
• Pulichino A. M., Vallette‐Kasic S., Couture C., Gauthier Y., Brue T., David M., et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003; 17: 711–6
   PubMed Web of Science ®Google Scholar
• Vallette‐Kasic S., Brue T., Pulichino A. M., Gueydan M., Barlier A., David M., et al. Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab 2005; 90: 1323–31
   PubMed Web of Science ®Google Scholar
• Metherell L. A., Savage M. O., Dattani M., Walker J., Clayton P. E., Farooqi I. S., et al. TPIT mutations are associated with early‐onset, but not late‐onset isolated ACTH deficiency. Eur J Endocrinol 2004; 151: 463–5
   PubMed Web of Science ®Google Scholar
• Weintrob N., Drouin J., Vallette‐Kasic S., Taub E., Marom D., Lebenthal Y., et al. Low estriol levels in the maternal triple‐marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene. Pediatrics 2006; 117: e322–e327
   PubMed Web of Science ®Google Scholar
• Suh H., Gage P. J., Drouin J., Camper S. A. Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 2002; 129: 329–37
   PubMed Web of Science ®Google Scholar
• Semina E. V., Reiter R., Leysens N. J., Alward W. L., Small K. W., Datson N. A., et al. Cloning and characterization of a novel bicoid‐related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996; 14: 392–9
   PubMed Web of Science ®Google Scholar
• Lin C. R., Kioussi C., O'Connell S., Briata P., Szeto D., Liu F., et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999; 401: 279–82
   PubMed Web of Science ®Google Scholar
• Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S. W., et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996; 14: 357–60
   PubMed Web of Science ®Google Scholar
• Roessler E., Du Y. Z., Mullor J. L., Casas E., Allen W. P., Gillessen‐Kaesbach G., et al. Loss‐of‐function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly‐like features. Proc Natl Acad Sci U S A 2003; 100: 13424–9
   PubMed Web of Science ®Google Scholar
• Fofanova O. V., Takamura N., Kinoshita E., Yoshimoto M., Tsuji Y., Peterkova V. A., et al. Rarity of PIT1 involvement in children from Russia with combined pituitary hormone deficiency. Am J Med Genet 1998; 77: 360–5
   PubMed Web of Science ®Google Scholar
• Rainbow L. A., Rees S. A., Shaikh M. G., Shaw N. J., Cole T., Barrett T. G., et al. Mutation analysis of POUF‐1, PROP‐1 and HESX‐1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo‐optic dysplasia. Clin Endocrinol (Oxf) 2005; 62: 163–8
   PubMed Web of Science ®Google Scholar
• Ezzat S., Mader R., Fischer S., Yu S., Ackerley C., Asa S. L. An essential role for the hematopoietic transcription factor Ikaros in hypothalamic‐pituitary‐mediated somatic growth. Proc Natl Acad Sci U S A 2006; 103: 2214–9
   PubMed Web of Science ®Google Scholar
• Ellsworth B. S., Egashira N., Haller J. L., Butts D. L., Cocquet J., Clay C. M., et al. FOXL2 in the Pituitary: Molecular, Genetic and Developmental Analysis. 0000, Mol Endocrinol. 2006 Jul 13; [Epub ahead of print]
   Google Scholar
• Douglas K. R., Brinkmeier M. L., Kennell J. A., Eswara P., Harrison T. A., Patrianakos A. I., et al. Identification of members of the Wnt signaling pathway in the embryonic pituitary gland. Mamm Genome 2001; 12: 843–51
   PubMed Web of Science ®Google Scholar
• Salemi S., Besson A., Eble A., Gallati S., Pfaffle R. W., Mullis P. E. New N‐terminal located mutation (Q4ter) within the POU1F1‐gene (PIT‐1) causes recessive combined pituitary hormone deficiency and variable phenotype. Growth Horm IGF Res 2003; 13: 264–8
   PubMed Web of Science ®Google Scholar
• Pellegrini‐Bouiller I., Belicar P., Barlier A., Gunz G., Charvet J. P., Jaquet P., et al. A new mutation of the gene encoding the transcription factor Pit‐1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996; 81: 2790–6
   PubMed Web of Science ®Google Scholar
• McLennan K., Jeske Y., Cotterill A., Cowley D., Penfold J., Jones T., et al. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clin Endocrinol (Oxf) 2003; 58: 785–94
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Cisternino M., Cohen L. E. A novel nonsense mutation in the Pit‐1 gene: evidence for a gene dosage effect. J Clin Endocrinol Metab 2003; 88: 1241–7
   PubMed Web of Science ®Google Scholar
• Wit J. M., Drayer N. M., Jansen M., Walenkamp M. J., Hackeng W. H., Thijssen J. H., et al. Total deficiency of growth hormone and prolactin, and partial deficiency of thyroid stimulating hormone in two Dutch families: a new variant of hereditary pituitary deficiency. Horm Res 1989; 32: 170–7
   PubMedGoogle Scholar
• Malvagia S., Poggi G. M., Pasquini E., Donati M. A., Pela I., Morrone A., et al. The de novo Q167K mutation in the POU1F1 gene leads to combined pituitary hormone deficiency in an Italian patient. Pediatr Res 2003; 54: 635–40
   PubMed Web of Science ®Google Scholar
• Brown M. R., Parks J. S., Adess M. E., Rich B. H., Rosenthal I. M., Voss T. C., et al. Central hypothyroidism reveals compound heterozygous mutations in the Pit‐1 gene. Horm Res 1998; 49: 98–102
   PubMed Web of Science ®Google Scholar
• Hendriks‐Stegeman B. I., Augustijn K. D., Bakker B., Holthuizen P., Der Vliet P. C., Jansen M. Combined pituitary hormone deficiency caused by compound heterozygosity for two novel mutations in the pou domain of the pit1/pou1f1 gene. J Clin Endocrinol Metab 2001; 86: 1545–50
   PubMed Web of Science ®Google Scholar
• Gat‐Yablonski G., Lazar L., Pertzelan A., Phillip M. A novel mutation in PIT‐1: phenotypic variability in familial combined pituitary hormone deficiencies. J Pediatr Endocrinol Metab 2002; 15: 325–30
   PubMed Web of Science ®Google Scholar
• Cohen L. E., Zanger K., Brue T., Wondisford F. E., Radovick S. Defective retinoic acid regulation of the Pit‐1 gene enhancer: A novel mechanism of combined pituitary hormone deficiency. Mol Endocrinol 1999; 13: 476–84
   PubMedGoogle Scholar
• Pernasetti F., Milner R. D., al Ashwal A. A., de Zegher F., Chavez V. M., Muller M., et al. Pro239Ser: a novel recessive mutation of the Pit‐1 gene in seven Middle Eastern children with growth hormone, prolactin, and thyrotropin deficiency. J Clin Endocrinol Metab 1998; 83: 2079–83
   PubMed Web of Science ®Google Scholar
• Gat‐Yablonski G., Klar A., Hirsch D., Eliakim A., Lazar L., Hurvitz H., et al. Three novel mutations in POU1F1 in Israeli patients with combined pituitary hormone deficiency. J Pediatr Endocrinol Metab 2005; 18: 385–93
   PubMed Web of Science ®Google Scholar
• Irie Y., Tatsumi K., Ogawa M., Kamijo T., Preeyasombat C., Suprasongsin C., et al. A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency. Endocr J 1995; 42: 351–4
   PubMed Web of Science ®Google Scholar
• Blankenstein O., Muhlenberg R., Kim C., Wuller S., Pfaffle R., Heimann G. A new C‐terminal located mutation (V272ter) in the PIT‐1 gene manifesting with severe congenital hypothyroidism. Possible functionality of the PIT‐1 C‐terminus. Horm Res 2001; 56: 81–6
   PubMedGoogle Scholar